Paper40765417
Advances in selenium-based nanomedicines for cardiovascular disease therapy: mechanisms, current trends, and prospects.
Li P and 6 others. Nanomedicine (Lond), 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Advances in selenium-based nanomedicines for cardiovascular disease therapy: mechanisms, current trends, and prospects. Papers, record 40765417. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40765417
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advances in selenium-based nanomedicines for cardiovascular disease therapy: mechanisms, current trends, and prospects.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Selenium | Major topic |
| Cardiovascular Diseases | Major topic |
| Nanoparticles | Major topic |
| Nanomedicine | Major topic |
| Humans | |
| Animals | |
| Antioxidants |
Source PubMed
References110
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31469318 | Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy. | Artif Cells Nanomed Biotechnol | 2019 | https://conductscience.org/library/papers/31469318 | PubMed |
| 2 | 30703423 | Construction of arabinogalactans/selenium nanoparticles composites for enhancement of the antitumor activity. | Int J Biol Macromol | 2019 | https://conductscience.org/library/papers/30703423 | PubMed |
| 3 | 14583345 | Free radical scavenging efficiency of Nano-Se in vitro. | Free Radic Biol Med | 2003 | https://conductscience.org/library/papers/14583345 | PubMed |
| 4 | 40379216 | Artificial lipids and macrophage membranes coassembled biomimetic nanovesicles for thoracic aortic dissection treatment. | J Control Release | 2025 | https://conductscience.org/library/papers/40379216 | PubMed |
| 5 | 31573569 | Systematic acute and subchronic toxicity evaluation of polysaccharide-protein complex-functionalized selenium nanoparticles with anticancer potency. | Biomater Sci | 2019 | https://conductscience.org/library/papers/31573569 | PubMed |
| 6 | 28499854 | Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich's ascites carcinoma bearing mice. | Eur J Pharm Biopharm | 2017 | https://conductscience.org/library/papers/28499854 | PubMed |
| 7 | 33905703 | Selenium nanoparticles inhibit the formation of atherosclerosis in apolipoprotein E deficient mice by alleviating hyperlipidemia and oxidative stress. | Eur J Pharmacol | 2021 | https://conductscience.org/library/papers/33905703 | PubMed |
| 8 | 28056992 | Antioxidant capacities of the selenium nanoparticles stabilized by chitosan. | J Nanobiotechnology | 2017 | https://conductscience.org/library/papers/28056992 | PubMed |
| 9 | 31051453 | Biosynthesis of Selenium Nanoparticles using yeast Nematospora coryli and examination of their anti-candida and anti-oxidant activities. | IET Nanobiotechnol | 2019 | https://conductscience.org/library/papers/31051453 | PubMed |
| 10 | 25248917 | A simple sonochemical approach for synthesis of selenium nanostructures and investigation of its light harvesting application. | Ultrason Sonochem | 2015 | https://conductscience.org/library/papers/25248917 | PubMed |
| 11 | 35997450 | Unveiling Antimicrobial and Insecticidal Activities of Biosynthesized Selenium Nanoparticles Using Prickly Pear Peel Waste. | J Funct Biomater | 2022 | https://conductscience.org/library/papers/35997450 | PubMed |
| 12 | 35624786 | The Role and Mechanisms of Selenium Supplementation on Fatty Liver-Associated Disorder. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35624786 | PubMed |
| 13 | 34121366 | Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics. | Adv Healthc Mater | 2021 | https://conductscience.org/library/papers/34121366 | PubMed |
| 14 | 39094922 | Unveiling Green Synthesis and Biomedical Theranostic paradigms of Selenium Nanoparticles (SeNPs) - A state-of-the-art comprehensive update. | Int J Pharm | 2024 | https://conductscience.org/library/papers/39094922 | PubMed |
| 15 | 35646508 | Citric acid-mediated green synthesis of selenium nanoparticles: antioxidant, antimicrobial, and anticoagulant potential applications. | Biomass Convers Biorefin | 2022 | https://conductscience.org/library/papers/35646508 | PubMed |
| 16 | 20306235 | Regulation of redox signaling by selenoproteins. | Biol Trace Elem Res | 2010 | https://conductscience.org/library/papers/20306235 | PubMed |
| 17 | 33849566 | Mutual influence of selenium nanoparticles and FGF2-STAB® on biocompatible properties of collagen/chitosan 3D scaffolds: in vitro and ex ovo evaluation. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/33849566 | PubMed |
| 18 | 36741999 | Preparation of nano-selenium from chestnut polysaccharide and characterization of its antioxidant activity. | Front Nutr | 2022 | https://conductscience.org/library/papers/36741999 | PubMed |
| 19 | 32077990 | Nanobiotechnology approach in intracellular selenium nanoparticle synthesis using Saccharomyces cerevisiae-fabrication and characterization. | Arch Microbiol | 2020 | https://conductscience.org/library/papers/32077990 | PubMed |
| 20 | 33323558 | Amorphous nano-selenium quantum dots prevent pulmonary arterial hypertension through recoupling endothelial nitric oxide synthase. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/33323558 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42528870 | Seasonal regulation of selenium biofortification in tea through Se-rich organic fertilizer application. | Front Plant Sci | 2026 | https://conductscience.org/library/papers/42528870 | PubMed |
| 42123474 | Amelioration of 5-Fluorouracil-Induced Hepatorenal Toxicity by Epigallocatechin Gallate-Functionalized Selenium Nanoparticles: A Multi-Targeted Protective Approach. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123474 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40765417
GET https://conductscience.org/api/papers/v1/40765417/references?page=2